Sio Gene Therapies Buy Hold or Sell Recommendation
SIOXDelisted Stock | USD 0.40 0.01 2.56% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Sio Gene Therapies is 'Not Rated'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Sio Gene Therapies given historical horizon and risk tolerance towards Sio Gene. When Macroaxis issues a 'buy' or 'sell' recommendation for Sio Gene Therapies, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. In addition, we conduct extensive research on individual companies such as Sio and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Sio Gene Therapies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Sio |
Execute Sio Gene Buy or Sell Advice
The Sio recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Sio Gene Therapies. Macroaxis does not own or have any residual interests in Sio Gene Therapies or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Sio Gene's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Not Rated
Sio Gene Trading Alerts and Improvement Suggestions
Sio Gene Therapies is not yet fully synchronised with the market data | |
Sio Gene Therapies has some characteristics of a very speculative penny stock | |
Sio Gene Therapies has a very high chance of going through financial distress in the upcoming years | |
Net Loss for the year was (71.89 M) with profit before overhead, payroll, taxes, and interest of 0. | |
Sio Gene Therapies currently holds about 54.77 M in cash with (60.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.74, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
Roughly 25.0% of the company outstanding shares are owned by corporate insiders |
Sio Gene Returns Distribution Density
The distribution of Sio Gene's historical returns is an attempt to chart the uncertainty of Sio Gene's future price movements. The chart of the probability distribution of Sio Gene daily returns describes the distribution of returns around its average expected value. We use Sio Gene Therapies price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Sio Gene returns is essential to provide solid investment advice for Sio Gene.
Mean Return | -0.09 | Value At Risk | -2.38 | Potential Upside | 2.33 | Standard Deviation | 1.89 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Sio Gene historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Sio Gene Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Sio . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 0.0714 | |||
Daily Balance Of Power | 0.3333 | |||
Rate Of Daily Change | 1.03 | |||
Day Median Price | 0.41 | |||
Day Typical Price | 0.4 | |||
Market Facilitation Index | 0.03 | |||
Period Momentum Indicator | 0.01 |
About Sio Gene Buy or Sell Advice
When is the right time to buy or sell Sio Gene Therapies? Buying financial instruments such as Sio Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Sio Gene in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Software Thematic Idea Now
Software
Companies that develop and distribute software and software systems to individuals or business. The Software theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Software Theme or any other thematic opportunities.
View All Next | Launch |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in Sio Stock
If you are still planning to invest in Sio Gene Therapies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sio Gene's history and understand the potential risks before investing.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |